• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于溶栓治疗的壳聚糖纳米粒载链激酶的片上制备

On-Chip Preparation of Streptokinase Entrapped in Chitosan Nanoparticles Used in Thrombolytic Therapy Potentially.

机构信息

Nano-Biopolymers Research Laboratory, School of Chemical Engineering, College of Engineering, University of Tehran, PO Box: 11155-4563, Tehran, Iran.

Nano-Biopolymers Research Laboratory, School of Chemical Engineering, College of Engineering, University of Tehran, PO Box: 11155-4563, Tehran, Iran.

出版信息

J Pharm Sci. 2017 Dec;106(12):3623-3630. doi: 10.1016/j.xphs.2017.08.001. Epub 2017 Aug 18.

DOI:10.1016/j.xphs.2017.08.001
PMID:28826879
Abstract

The objective of this work was to prepare the streptokinase (SK) entrapped in chitosan nanoparticles (CS NPs) using bulk mixing (BM) and microfluidic (MF) techniques. The physicochemical properties of the samples were characterized by means of scanning electron microscopy and dynamic light scattering analysis for optimizing CS and SK solution concentrations as well as pH values. The obtained results showed that CS NPs fabricated using MF chip have the most uniform morphology, spherical shape, and average diameter of 67 ± 13 nm along with a narrow polydispersity. Conversely, the NP samples prepared via BM method have an irregular and disordered morphology as well as a broad distribution in their particle size (452 ± 300 nm). The in vitro drug release from microfluidically generated CS NPs depicted the controlled release of SK without plateau regime compared to those samples prepared using BM method during 48 h. Also, the drug release kinetic followed Higuchi model which revealed that the Fickian diffusion was the predominant mechanism. Subsequently, in in vivo animal model test, the performance of SK in blood plasma exhibited higher amidolytic activity for SK entrapped in CS NP samples fabricated via MF technique compared to those NPs prepared using BM and also SK alone.

摘要

本工作旨在使用批量混合(BM)和微流控(MF)技术将链激酶(SK)包封于壳聚糖纳米颗粒(CS NPs)中。通过扫描电子显微镜和动态光散射分析对样品的物理化学性质进行了表征,以优化 CS 和 SK 溶液浓度以及 pH 值。结果表明,使用 MF 芯片制备的 CS NPs 具有最均匀的形态、球形形状和平均直径为 67±13nm 以及较窄的多分散性。相反,通过 BM 方法制备的 NP 样品具有不规则和无序的形态以及粒径分布较宽(452±300nm)。与通过 BM 方法制备的样品相比,微流化生成的 CS NPs 体外药物释放显示 SK 的控制释放,没有平台期,在 48 小时内。此外,药物释放动力学遵循 Higuchi 模型,表明菲克扩散是主要机制。随后,在体内动物模型试验中,SK 在血浆中的性能表现出更高的 amidolytic 活性,对于通过 MF 技术制备的 CS NP 样品中包封的 SK 与通过 BM 制备的那些 NPs 以及 SK 本身相比。

相似文献

1
On-Chip Preparation of Streptokinase Entrapped in Chitosan Nanoparticles Used in Thrombolytic Therapy Potentially.用于溶栓治疗的壳聚糖纳米粒载链激酶的片上制备
J Pharm Sci. 2017 Dec;106(12):3623-3630. doi: 10.1016/j.xphs.2017.08.001. Epub 2017 Aug 18.
2
Microfluidic-aided fabrication of nanoparticles blend based on chitosan for a transdermal multidrug delivery application.基于壳聚糖的纳米颗粒混合物的微流控辅助制备用于经皮多药递送应用
Int J Biol Macromol. 2017 Jun;99:433-442. doi: 10.1016/j.ijbiomac.2017.03.013. Epub 2017 Mar 6.
3
Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.海藻酸包覆壳聚糖核壳纳米粒经口递送依诺肝素:体外与体内评价。
Int J Pharm. 2013 Nov 1;456(1):31-40. doi: 10.1016/j.ijpharm.2013.08.037. Epub 2013 Aug 29.
4
Preparation and characterization of polyelectrolyte complex nanoparticles based on poly (malic acid), chitosan. A pH-dependent delivery system.基于聚(苹果酸)、壳聚糖的聚电解质复合纳米颗粒的制备与表征。一种pH依赖性递送系统。
J Biomater Sci Polym Ed. 2017 Jan;28(1):50-62. doi: 10.1080/09205063.2016.1242460. Epub 2016 Oct 13.
5
Microfluidic-based synthesized carboxymethyl chitosan nanoparticles containing metformin for diabetes therapy: In vitro and in vivo assessments.基于微流控技术合成的载二甲双胍羧甲基壳聚糖纳米粒用于糖尿病治疗的研究:体外和体内评价。
Carbohydr Polym. 2021 Jun 1;261:117889. doi: 10.1016/j.carbpol.2021.117889. Epub 2021 Mar 3.
6
Development and physicochemical, toxicity and immunogenicity assessments of recombinant hepatitis B surface antigen (rHBsAg) entrapped in chitosan and mannosylated chitosan nanoparticles: as a novel vaccine delivery system and adjuvant.壳聚糖和甘露糖化壳聚糖纳米粒包封重组乙型肝炎表面抗原(rHBsAg)的研制及其理化性质、毒性和免疫原性评估:作为一种新型疫苗传递系统和佐剂。
Artif Cells Nanomed Biotechnol. 2018;46(sup1):230-240. doi: 10.1080/21691401.2017.1417868. Epub 2017 Dec 20.
7
Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis.载雷洛昔芬壳聚糖纳米粒的制备、研制与优化及其在骨质疏松治疗中的应用。
Drug Deliv. 2015;22(6):823-36. doi: 10.3109/10717544.2014.900153. Epub 2014 Apr 14.
8
Glycyrrhizin conjugated chitosan nanoparticles for hepatocyte-targeted delivery of lamivudine.用于拉米夫定肝细胞靶向递送的甘草酸共轭壳聚糖纳米颗粒。
J Pharm Pharmacol. 2014 Aug;66(8):1082-93. doi: 10.1111/jphp.12235. Epub 2014 Mar 19.
9
Preparation and characterization of self-assembled chitosan nanoparticles for the sustained delivery of streptokinase: an in vivo study.自组装壳聚糖纳米粒的制备及特性研究——用于链激酶的持续释放:体内研究。
Pharm Dev Technol. 2014 Aug;19(5):593-7. doi: 10.3109/10837450.2013.813542. Epub 2013 Jul 17.
10
Preparation of PEG-grafted chitosan/streptokinase nanoparticles to improve biological half-life and reduce immunogenicity of the enzyme.制备聚乙二醇接枝壳聚糖/链激酶纳米粒以提高酶的生物半衰期并降低其免疫原性。
Int J Biol Macromol. 2020 Jan 15;143:181-189. doi: 10.1016/j.ijbiomac.2019.11.157. Epub 2019 Nov 20.

引用本文的文献

1
Precise nanoscale fabrication technologies, the "last mile" of medicinal development.精确的纳米级制造技术,药物研发的“最后一公里”。
Acta Pharm Sin B. 2025 May;15(5):2372-2401. doi: 10.1016/j.apsb.2025.03.040. Epub 2025 Mar 18.
2
Industrial applications of immobilized nano-biocatalysts.固定化纳米生物催化剂的工业应用。
Bioprocess Biosyst Eng. 2022 Feb;45(2):237-256. doi: 10.1007/s00449-021-02647-y. Epub 2021 Oct 1.
3
Thrombolytic Agents: Nanocarriers in Controlled Release.溶栓剂:控释纳米载体
Small. 2020 Oct;16(40):e2001647. doi: 10.1002/smll.202001647. Epub 2020 Aug 12.
4
An in vitro Model System for Evaluating Remote Magnetic Nanoparticle Movement and Fibrinolysis.用于评估远程磁性纳米颗粒运动和纤维蛋白溶解的体外模型系统。
Int J Nanomedicine. 2020 Mar 9;15:1549-1568. doi: 10.2147/IJN.S237395. eCollection 2020.
5
Microfluidization trends in the development of nanodelivery systems and applications in chronic disease treatments.微流化技术在纳米递药系统开发中的发展趋势及其在慢性病治疗中的应用。
Int J Nanomedicine. 2018 Oct 9;13:6109-6121. doi: 10.2147/IJN.S178077. eCollection 2018.